| Financial Year |
March 31 2023 |
| Monetary Funds |
267,654,144.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
137,722,599.32 |
| Accounts Receivable |
352,495,244.69 |
| Advances to Suppliers |
58,161,942.06 |
| Other Receivables |
1,098,629.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
398,049,247.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
1,260,773,366.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
60,235,561.13 |
| Fixed Assetes |
196,658,258.20 |
| Under-construction Projects |
47,169.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
46,300,459.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
7,008,036.70 |
| Other Non-Current Assets |
6,000.00 |
| Sub-Total of Non-Current Assets |
322,385,564.50 |
| Total Assets |
1,583,158,930.97 |
| Short-Term Loans |
93,532,041.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
255,496,296.00 |
| Accounts Payable |
235,315,635.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,948.78 |
| Taxes Payable |
23,536,985.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,393,604.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,568,528.05 |
| Other Current Liabilities |
912,945.50 |
| Sub-Total of Current Liabilities |
646,818,643.37 |
| Long-term Loans |
290,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
302,659,131.84 |
| Total Liabilities |
949,477,775.21 |
| Paid-In Capital(Or Share Stock) |
248,112,330.00 |
| Capital Surplus |
1,158,273,010.54 |
| Surplus Reserve |
43,820,454.38 |
| LESS:Treasury Stock |
11,143,500.00 |
| Undistributed Profits |
-805,381,139.16 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
633,681,155.76 |
| Owner's Equity（Stockholder's Equity） |
633,681,155.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,583,158,930.97 |
